DLA Piper represented Olive (formerly known as CrossChx), a Columbus, Ohio-based technology company applying artificial intelligence to healthcare administration, in its US$32.8 million Series D financing. The financing was led by Oak HC/FT and Ascension Ventures, with participation by existing investors.
The funding provides the company with the capital to fuel the growth of the company's eponymous AI solution throughout healthcare organizations nationwide, and invest in new capabilities such as Pupil, its processing mining tool that will be launched on alpha sites in the coming months.
The DLA Piper team representing Olive was led by partner Matthew Gorra (Baltimore) and associate Jay Buchanan (Austin) and included partner Julia Kovacs (Washington, DC), of counsel Paul Myers (Baltimore), and attorney Laura Acton (Baltimore).
DLA Piper's healthcare, life sciences and technology sector attorneys provide advice to private and public companies, investors, owners and entrepreneurs. Last year, according to Mergermarket's league tables for legal advisors, DLA Piper again earned the top ranking globally for overall deal volume and ranked first for technology M&A in the US. DLA Piper was highly ranked in other notable league tables for 2017, including placing in the top five of each M&A, venture capital and private equity category recognized by PitchBook – the only law firm to do so.